Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00378482
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2006-09-19
Brief Title:
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued
Sponsor:
Organization:
AstraZeneca